- Home
- Equipment
- asia middle east
- arterial disease
Refine by
Locations
- Asia & Middle East
- Afghanistan
- Armenia
- Azerbaijan
- Bahrain
- Bangladesh
- Bhutan
- Brunei Darussalam
- Cambodia
- China
- East Timor
- Georgia
- Guam
- India
- Indonesia
- Iran
- Iraq
- Israel
- Japan
- Jordan
- Kazakhstan
- Kuwait
- Kyrgyzstan
- Laos
- Lebanon
- Malaysia
- Maldives
- Mongolia
- Myanmar
- Nepal
- North Korea
- Oman
- Pakistan
- Palestinian Territories
- Philippines
- Qatar
- Russia
- Saudi Arabia
- Singapore
- South Korea
- Sri Lanka
- Syria
- Taiwan
- Tajikistan
- Thailand
- Turkmenistan
- United Arab Emirates
- Uzbekistan
- Vietnam
- Yemen
Arterial Disease Equipment Supplied In Asia Middle East
16 equipment items found
Manufactured by:Pharmigene, Inc. based inNeihu Dist, TAIWAN
Clodpgrel, an antiplatelet agents is indicated for the reduction of thrombotic events as follows: Recent MI, Recent Stroke or Established Peripheral Arterial Disease. For patients with a history of recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease, Clopidogrel has been shown to reduce ...
Manufactured by:Concept Medical Inc. based inTampa, FLORIDA (USA)
AN EXCELLENT ALTERNATIVE FOR REVASCULAZATION OF SFA AND BTK ARTERIES.MagicTouch PTA is intended to prevent re-narrowing of superficial femoral and popliteal arteries in patients with peripheral artery ...
Manufactured by:Concept Medical Inc. based inTampa, FLORIDA (USA)
Novel, First of its kind Sirolimus drug coated balloon catheter for the treatment coronary artery disease. MagicTouch is intended for in-stent restenosis, small vessels, bifurcation lesions and de-novo lesions ...
Manufactured by:ACME Portable Machines, Inc. based inNew Taipei City, TAIWAN
It is a patented algorithm that analyzes 10 second 12 lead ECG captured by either our own QED 2000 or a certified off-the-shelf ECG machine, and it aims to assist in detection of myocardial ischemia related to Coronary Artery Disease ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
BioPath 035 is a drug-eluting balloon dilatation catheter designed for percutaneous transluminal angioplasty (PTA) and has been optimized for the treatment of patients with peripheral arterial disease. BioPath 035 is intended for peripheral interventions above the knee. This paclitaxel-eleluting balloon feature a proprietary shellac coating technology which ...
Manufactured by:Concept Medical Inc. based inTampa, FLORIDA (USA)
ABLUMINUS DES+ designed by propriety ENVISOLUTION technology in a way that address the unmet clinical needs specially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease. ABLUMINUS DES+ Receives on-label indication for Diabetes Mellitus and Acute Myocardial infarction. ...
Manufactured by:Biosensors International Group, Ltd. based inSingapore, SINGAPORE
Designed for below the knee interventions: BioPath 014 is a drug-eluting balloon dilatation catheter designed for percutaneous transluminal angioplasty (PTA) and has been optimized for the treatment of patients with peripheral arterial disease. BioPath 014 is intended for infrapopliteal interventions below the knee. This paclitaxel-eluting balloon feature a ...
Manufactured by:Stempeutics Research Pvt. Ltd. based inBangalore, INDIA
In August 2020, Drug Controller General of India (DCGI) has granted manufacturing and marketing approval of Stempeucel® product for the treatment of CLI due to Buerger’s Disease and CLI due to Atherosclerotic Peripheral Arterial Disease. Stempeucel® becomes the first allogeneic cell therapy product to be approved for commercial use ...
Manufactured by:Perimed AB based inJarfälla, SWEDEN
The most versatile and adaptable tcpO2 solution on the market. From small wound care centers to large university hospitals, PeriFlux 6000 – tcpO2 can be customized to your ...
Manufactured by:Perimed AB based inJarfälla, SWEDEN
Our sensitive laser Doppler technique provides accurate toe pressure measurements. By adding the SPP technique, a more comprehensive wound healing assessment can be obtained. All pressure tests are easy and fast to perform thanks to our user-friendly software and intuitive labeling. ...
Manufactured by:CHISON Medical Technologies Co., Ltd. based inWuxi, CHINA
A revolutionary invention with everything you can imagine makes you more ...
Manufactured by:Myra & Co. based inGhaziabad, INDIA
FusionKraft range of preferred Cardio-Thoracic & Vascular Surgical Instruments is a comprehensive selection of specialized surgical essentials dealing into the management of the ailments of the organs inside the Thorax (the chest) – generally diagnosis & treatment of the conditions of the heart (involving heart & great vessels) & lungs ...
Manufactured by:Zarya Group based inNizhniy Novgorod, RUSSIA
Magnitoturbotron is a physiotherapy equipment for systemic magnetotherapy. The device has a capsule-like form with a large diameter inductor installed ...
Manufactured by:Medispec based inGaithersburg, MARYLAND (USA)
The ESMR therapy is a non-invasive therapy approach using Extracorporeal Shockwave technology for Myocardial Revascularization. Ischemic myocardial areas no longer accessible by conventional revascularization therapies could be treated with the Cardiospec ESMR therapy to relieve symptoms resulted from the myocardial ischemia. The treatment is performed using a shock wave generator that is ...
by:Nano-X Imaging Ltd. based inNeve Ilan, ISRAEL
Healthcare providers and payers can now benefit from AI medical imaging technology to screen for early signs of chronic disease in large populations. Nanox Ai enables more accurate risk-adjustment so patients are provided with preventative care paths they need, while improving quality of health services at significantly lower associated costs. ...
Manufactured by:Siemens Healthcare GmbH based inErlangen, GERMANY
The healthcare market is driven by the need to enhance efficiency and efficacy. Delivering on both, minimally invasive image-guided therapies are changing the way healthcare can be provided. And the market is growing: The global population aged 60 and older is projected to reach nearly 2.1 billion by 2050, versus 962 million in 2017.1 This means that the number of patients in all fields will be ...